BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 16082771)

  • 1. Inhibition of mammary tumor growth by a novel nontoxic retinoid: chemotherapeutic evaluation of a C-linked analog of 4-HPR-glucuronide.
    Alshafie GA; Walker JR; Curley RW; Clagett-Dame M; Highland MA; Nieves NJ; Stonerock LA; Abou-Issa H
    Anticancer Res; 2005; 25(3c):2391-8. PubMed ID: 16082771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemopreventive activity of a C-glucuronide analog of N-(4-hydroxyphenyl) retinamide-O-glucuronide against mammary tumor development and growth.
    Abou-Issa HM; Alshafie GA; Curley RW; Wong MF; Clagett-Dame M; Repa JJ; Sikri V
    Anticancer Res; 1999; 19(2A):999-1004. PubMed ID: 10368645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapeutic evaluation of N-(4-hydroxyphenyl) retinamide-O-glucuronide in the rat mammary tumor model.
    Abou-Issa H; Curley RW; Panigot MJ; Tanagho SN; Sidhu BS; Alshafie GA
    Anticancer Res; 1997; 17(5A):3335-9. PubMed ID: 9413168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapeutic evaluation of 4-hydroxybenzylretinone (4-HBR), a nonhydrolyzable C-linked analog of N-(4-hydroxyphenyl) retinamide (4-HPR) against mammary carcinogenesis.
    Abou-Issa H; Curley RW; Alshafie GA; Weiss KL; Clagett-Dame M; Chapman JS; Mershon SM
    Anticancer Res; 2001; 21(6A):3839-44. PubMed ID: 11911255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo use of N-(4-hydroxyphenyl retinamide)-0-glucuronide as a breast cancer chemopreventive agent.
    Abou-Issa H; Curley RW; Panigot MJ; Wilcox KA; Webb TE
    Anticancer Res; 1993; 13(5A):1431-6. PubMed ID: 8239515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemopreventive activities of C-glucuronide/glycoside analogs of retinoid-O-glucuronides against breast cancer development and growth.
    Curley RW; Abou-Issa H; Panigot MJ; Repa JJ; Clagett-Dame M; Alshafie G
    Anticancer Res; 1996; 16(2):757-63. PubMed ID: 8687125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and preliminary chemotherapeutic evaluation of the fully C-linked glucuronide of N-(4-hydroxyphenyl)retinamide.
    Walker JR; Alshafie G; Nieves N; Ahrens J; Clagett-Dame M; Abou-Issa H; Curley RW
    Bioorg Med Chem; 2006 May; 14(9):3038-48. PubMed ID: 16412653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An improved synthesis of the C-linked glucuronide of N-(4-hydroxyphenyl)retinamide.
    Walker JR; Alshafie G; Abou-Issa H; Curley RW
    Bioorg Med Chem Lett; 2002 Sep; 12(17):2447-50. PubMed ID: 12161154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of the fenretinide metabolite 4-oxo-fenretinide present in human plasma and formed in human ovarian carcinoma cells through induction of cytochrome P450 26A1.
    Villani MG; Appierto V; Cavadini E; Valsecchi M; Sonnino S; Curley RW; Formelli F
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6265-75. PubMed ID: 15448016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of retinyl acetate and 4-hydroxyphenylretinamide on initiation of chemically-induced mammary tumors.
    Grubbs CJ; Eto I; Juliana MM; Hardin JM; Whitaker LM
    Anticancer Res; 1990; 10(3):661-6. PubMed ID: 2142393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The peptidomimetic, 1-adamantyl-substituted, and flex-het classes of retinoid-derived molecules: structure-activity relationships and retinoid receptor-independent anticancer activities.
    Dawson MI; Fontana JA
    Mini Rev Med Chem; 2010 Jun; 10(6):455-91. PubMed ID: 20370709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An unhydrolyzable analogue of N-(4-hydroxyphenyl)retinamide. synthesis and preliminary biological studies.
    Weiss KL; Alshafie G; Chapman JS; Mershon SM; Abou-Issa H; Clagett-Dame M; Curley RW
    Bioorg Med Chem Lett; 2001 Jun; 11(12):1583-6. PubMed ID: 11412986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemoprevention of skin carcinogenesis by phenylretinamides: retinoid receptor-independent tumor suppression.
    Xu H; Cheepala S; McCauley E; Coombes K; Xiao L; Fischer SM; Clifford JL
    Clin Cancer Res; 2006 Feb; 12(3 Pt 1):969-79. PubMed ID: 16467112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 4-oxo-fenretinide, a recently identified fenretinide metabolite, induces marked G2-M cell cycle arrest and apoptosis in fenretinide-sensitive and fenretinide-resistant cell lines.
    Villani MG; Appierto V; Cavadini E; Bettiga A; Prinetti A; Clagett-Dame M; Curley RW; Formelli F
    Cancer Res; 2006 Mar; 66(6):3238-47. PubMed ID: 16540676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth suppression of human breast carcinoma cells in culture by N-(4-hydroxyphenyl)retinamide and its glucuronide and through synergism with glucarate.
    Bhatnagar R; Abou-Issa H; Curley RW; Koolemans-Beynen A; Moeschberger ML; Webb TE
    Biochem Pharmacol; 1991 May; 41(10):1471-7. PubMed ID: 1826840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative efficacy of glucarate on the initiation and promotion phases of rat mammary carcinogenesis.
    Abou-Issa H; Moeschberger M; el-Masry W; Tejwani S; Curley RW; Webb TE
    Anticancer Res; 1995; 15(3):805-10. PubMed ID: 7645962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative chemopreventive activity of ibuprofen and N-(4-hydroxyphenyl) retinamide against the development and growth of rat mammary adenocarcinomas.
    Alshafie GA; Harris RE; Robertson FM; Parrett ML; Ross M; Abou-Issa H
    Anticancer Res; 1999; 19(4B):3031-6. PubMed ID: 10652588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor efficacy of tangeretin by targeting the oxidative stress mediated on 7,12-dimethylbenz(a) anthracene-induced proliferative breast cancer in Sprague-Dawley rats.
    Periyasamy K; Baskaran K; Ilakkia A; Vanitha K; Selvaraj S; Sakthisekaran D
    Cancer Chemother Pharmacol; 2015 Feb; 75(2):263-72. PubMed ID: 25431347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinoid receptor-dependent and independent biological activities of novel fenretinide analogues and metabolites.
    Sabichi AL; Xu H; Fischer S; Zou C; Yang X; Steele VE; Kelloff GJ; Lotan R; Clifford JL
    Clin Cancer Res; 2003 Oct; 9(12):4606-13. PubMed ID: 14555536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapeutic evaluation of glucarate and N-(4-hydroxyphenyl)retinamide alone and in combination in the rat mammary tumor model.
    Abou-Issa H; Webb TE; Minton JP; Moeschberger M
    J Natl Cancer Inst; 1989 Dec; 81(23):1820-3. PubMed ID: 2531231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.